119 related articles for article (PubMed ID: 23614918)
21. Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors.
Taniuchi K; Yamada Y; Nonomura A; Takehara K
J Cutan Pathol; 1997 Aug; 24(7):393-7. PubMed ID: 9274955
[TBL] [Abstract][Full Text] [Related]
22. Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
Chen YT; Chen WT; Huang WT; Wu CC; Chai CY
Kaohsiung J Med Sci; 2012 Oct; 28(10):545-9. PubMed ID: 23089320
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
West KL; Cardona DM; Su Z; Puri PK
Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
[TBL] [Abstract][Full Text] [Related]
24. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
[TBL] [Abstract][Full Text] [Related]
25. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.
Wang J; Morimitsu Y; Okamoto S; Hisaoka M; Ishida T; Sheng W; Hashimoto H
J Mol Diagn; 2000 Feb; 2(1):47-52. PubMed ID: 11272901
[TBL] [Abstract][Full Text] [Related]
26. Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.
Saeki H; Hoashi T; Tada Y; Ashida R; Kuwano Y; Le Pavoux A; Tsunemi Y; Shikada J; Torii H; Kawabata Y; Kikuchi K; Tamada Y; Matsumoto Y; Tamaki K
J Dermatol Sci; 2003 Dec; 33(3):161-7. PubMed ID: 14643521
[TBL] [Abstract][Full Text] [Related]
27. A rapid and efficient newly established method to detect COL1A1-PDGFB gene fusion in dermatofibrosarcoma protuberans.
Yokoyama Y; Shimizu A; Okada E; Ishikawa O; Motegi S
Biochem Biophys Res Commun; 2012 Aug; 425(2):353-6. PubMed ID: 22842571
[TBL] [Abstract][Full Text] [Related]
28. Comparison of p53 expression in dermatofibrosarcoma protuberans and dermatofibroma: lack of correlation with proliferation rate.
Díaz-Cascajo C; Bastida-Iñarrea J; Borrego L; Carretero-Hernández G
J Cutan Pathol; 1995 Aug; 22(4):304-9. PubMed ID: 7499569
[TBL] [Abstract][Full Text] [Related]
29. [Detection of COL1A1/PDGFB fusion transcripts in dermatofibroscoma protuberans by revers transcriptase-polymerase chain reaction using paraffin-embedded tissues].
Yang JH; Hu WH; Li F; Lu TC; Li HA; Chang B; Zhang XB; Zhou XM; Dang HW
Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):409-12. PubMed ID: 14633450
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of phosphorylated-STAT3 and phosphorylated-ERK protein in dermatofibrosarcoma protuberans.
Lin N; Urabe K; Moroi Y; Uchi H; Nakahara T; Dainichi T; Kokuba H; Tu Y; Furue M
Eur J Dermatol; 2006; 16(3):262-5. PubMed ID: 16709490
[TBL] [Abstract][Full Text] [Related]
31. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
Lee CS; Chou ST
Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
[TBL] [Abstract][Full Text] [Related]
32. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
33. ETS-related Gene (ERG) is Differentially Expressed in Dermatofibroma (Fibrous Histiocytoma) as Compared With Dermatofibrosarcoma Protuberans and Hypertrophic Scars: A Pilot Immunohistochemical Study.
Hengy M; Veenstra J; Perry K; Ozog DM; Friedman BJ
Appl Immunohistochem Mol Morphol; 2022 Jul; 30(6):453-458. PubMed ID: 35510745
[TBL] [Abstract][Full Text] [Related]
34. nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors.
Lee CS; Clarke RA; Tran KT; Kearsley JH; Chou ST
Pathology; 1999 May; 31(2):123-6. PubMed ID: 10399167
[TBL] [Abstract][Full Text] [Related]
35. Dermatofibroma and dermatofibrosarcoma protuberans: a comparative ultrastructural study.
Dominguez-Malagon H; Valdez-Carrillo Mdel C; Cano-Valdez AM
Ultrastruct Pathol; 2006; 30(4):283-91. PubMed ID: 16971353
[TBL] [Abstract][Full Text] [Related]
36. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
Kazlouskaya V; Malhotra S; Kabigting FD; Lal K; Elston DM
Am J Dermatopathol; 2014 May; 36(5):392-6. PubMed ID: 24247571
[TBL] [Abstract][Full Text] [Related]
37. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
[TBL] [Abstract][Full Text] [Related]
38. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
39. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
[TBL] [Abstract][Full Text] [Related]
40. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
